Cardinal Health

Rank: 7
2015 Rank6
R&D Spend:$0
Fiscal year ending:06-30-15
Click here to see all 100

Cardinal Health in May 2014 closed the $320 million acquisition of AccessClosure and its Mynx extravascular closure technology. In April 2015, the company agreed to disgorge nearly $27 million to settle charges that it exercised an illegal monopoly on low-energy radiopharmaceuticals. A month later, Johnson and Johnson accepted Cardinal's binding offer worth about $2 billion for its Cordis stent-making arm.

Cardinal Health Supportive Culture for Executive Women Recognized by National Association for Female Executives. Cardinal Health Ranked Among Most LGBT-Inclusive Places to Work in 2016. Cardinal Health Completes Acquisition Of Cordis. Cardinal Health Introduces Hospital Quality at Home™ Products. Cardinal Health Helps Position Independent Pharmacists to Win at 25th Annual Retail Business Conference. Cardinal Health Continues Support of Future Pharmacists with 2015 Scholarship Funding Exceeding $1 Million. Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion. Cardinal Health Among 64 Employers Recognized by National Business Group for Promoting Healthy Lifestyles. Cardinal Health Named One of the "Top 50 Companies for Executive Women" by NAFE.

2015 Top 500 Solar Contractors Key Personnel: George Barrett, Chairman & CEO; Michael Buck, President, Medical Products; Donald Casey Jr., CEO, Medical; Craig Cowman, EVP, Global Sourcing; Joseph DePinto, President, Specialty Health Solutions; Mike Duffy, President, Hospital Solutions & Global Supply Chain; Brian Ellis, EVP, Enterprise Accounts; Jon Giacomin, CEO, Pharmaceutical; Susan Jacobson, Deputy GC; Mike Kaufmann, CFO; Pamela Kimmet, Chief HR Officer; Craig Morford, Chief Legal & Compliance Officer; Patricia Morrison, EVP, Customer Services & CIO; Bill Owad, SVP, Operational Excellence; Tiffany Olson, President, Nuclear Pharmacy Services; David Wilson, President, Cordis;

7000 Cardinal Place
Dublin, Ohio